A-kinase Anchoring Proteins As Potential Drug Targets

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 2011 Nov 30

PMID 22122509

Citations 51

Authors

Jessica Troger

Marie C Moutty

Philipp Skroblin

Enno Klussmann

Affiliations

Soon will be listed here.

Abstract

A-kinase anchoring proteins (AKAPs) crucially contribute to the spatial and temporal control of cellular signalling. They directly interact with a variety of protein binding partners and cellular constituents, thereby directing pools of signalling components to defined locales. In particular, AKAPs mediate compartmentalization of cAMP signalling. Alterations in AKAP expression and their interactions are associated with or cause diseases including chronic heart failure, various cancers and disorders of the immune system such as HIV. A number of cellular dysfunctions result from mutations of specific AKAPs. The link between malfunctions of single AKAP complexes and a disease makes AKAPs and their interactions interesting targets for the development of novel drugs. LINKED ARTICLES This article is part of a themed section on Novel cAMP Signalling Paradigms. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2012.166.issue-2.

Citing Articles

Sex differences in the role of AKAP12 in behavioral function of middle-aged mice.

Ishikawa H, Kimura S, Takase H, Borlongan M, Fukuda N, Hoshino T Biol Sex Differ. 2024; 15(1):93.

PMID: 39574214 PMC: 11580627. DOI: 10.1186/s13293-024-00670-8.

The focal adhesion protein talin is a mechanically gated A-kinase anchoring protein.

Kang M, Otani Y, Guo Y, Yan J, Goult B, Howe A Proc Natl Acad Sci U S A. 2024; 121(13):e2314947121.

PMID: 38513099 PMC: 10990152. DOI: 10.1073/pnas.2314947121.

Comparative Analysis of Differential Cellular Transcriptome and Proteome Regulation by HIV-1 and HIV-2 Pseudovirions in the Early Phase of Infection.

Linkner T, Ambrus V, Kunkli B, Szojka Z, Kallo G, Csosz E Int J Mol Sci. 2024; 25(1).

PMID: 38203551 PMC: 10779251. DOI: 10.3390/ijms25010380.

Role of A-Kinase Anchoring Protein 12 in the Central Nervous System.

Kimura S, Lok J, Gelman I, Lo E, Arai K J Clin Neurol. 2023; 19(4):329-337.

PMID: 37417430 PMC: 10329933. DOI: 10.3988/jcn.2023.0095.

Transcriptome Analysis of Diffuse Large B-Cell Lymphoma Cells Inducibly Expressing MyD88 L265P Mutation Identifies Upregulated CD44, LGALS3, NFKBIZ, and BATF as Downstream Targets of Oncogenic NF-κB Signaling.

Turi M, Sithara A, Hofmanova L, Zihala D, Radhakrishnan D, Vdovin A Int J Mol Sci. 2023; 24(6).

PMID: 36982699 PMC: 10057398. DOI: 10.3390/ijms24065623.

References

Su B, Bu Y, Engelberg D, Gelman I . SSeCKS/Gravin/AKAP12 inhibits cancer cell invasiveness and chemotaxis by suppressing a protein kinase C- Raf/MEK/ERK pathway. J Biol Chem. 2009; 285(7):4578-86. PMC: 2836062. DOI: 10.1074/jbc.M109.073494. View

Chiriva-Internati M, Ferrari R, Yu Y, Hamrick C, Gagliano N, Grizzi F . AKAP-4: a novel cancer testis antigen for multiple myeloma. Br J Haematol. 2008; 140(4):465-8. DOI: 10.1111/j.1365-2141.2007.06940.x. View

Medrihan L, Rohlmann A, Fairless R, Andrae J, Doring M, Missler M . Neurobeachin, a protein implicated in membrane protein traffic and autism, is required for the formation and functioning of central synapses. J Physiol. 2009; 587(Pt 21):5095-106. PMC: 2790251. DOI: 10.1113/jphysiol.2009.178236. View

Tao J, Shumay E, McLaughlin S, Wang H, Malbon C . Regulation of AKAP-membrane interactions by calcium. J Biol Chem. 2006; 281(33):23932-44. DOI: 10.1074/jbc.M601813200. View

Castermans D, Wilquet V, Parthoens E, Huysmans C, Steyaert J, Swinnen L . The neurobeachin gene is disrupted by a translocation in a patient with idiopathic autism. J Med Genet. 2003; 40(5):352-6. PMC: 1735479. DOI: 10.1136/jmg.40.5.352. View

Lu Y, Allen M, Halt A, Weisenhaus M, Dallapiazza R, Hall D . Age-dependent requirement of AKAP150-anchored PKA and GluR2-lacking AMPA receptors in LTP. EMBO J. 2007; 26(23):4879-90. PMC: 2099463. DOI: 10.1038/sj.emboj.7601884. View

Xia W, Unger P, Miller L, Nelson J, Gelman I . The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer. Cancer Res. 2001; 61(14):5644-51. View

OConnor C, Miller A, Blair J, Konstam M, Wedge P, Bahit M . Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST).... Am Heart J. 2010; 159(5):841-849.e1. DOI: 10.1016/j.ahj.2010.02.023. View

Wong W, Scott J . AKAP signalling complexes: focal points in space and time. Nat Rev Mol Cell Biol. 2004; 5(12):959-70. DOI: 10.1038/nrm1527. View

10.

Tunquist B, Hoshi N, Guire E, Zhang F, Mullendorff K, Langeberg L . Loss of AKAP150 perturbs distinct neuronal processes in mice. Proc Natl Acad Sci U S A. 2008; 105(34):12557-62. PMC: 2527950. DOI: 10.1073/pnas.0805922105. View

11.

DellAcqua M, Faux M, Thorburn J, Thorburn A, Scott J . Membrane-targeting sequences on AKAP79 bind phosphatidylinositol-4, 5-bisphosphate. EMBO J. 1998; 17(8):2246-60. PMC: 1170569. DOI: 10.1093/emboj/17.8.2246. View

12.

Wells J, McClendon C . Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature. 2007; 450(7172):1001-9. DOI: 10.1038/nature06526. View

13.

Wu W, Zhang J, Yang H, Shao Y, Yu B . Examination of AKAP12 promoter methylation in skin cancer using methylation-sensitive high-resolution melting analysis. Clin Exp Dermatol. 2011; 36(4):381-5. DOI: 10.1111/j.1365-2230.2010.03968.x. View

14.

Huang L, Wang L, Ma Y, Durick K, Perkins G, Deerinck T . NH2-Terminal targeting motifs direct dual specificity A-kinase-anchoring protein 1 (D-AKAP1) to either mitochondria or endoplasmic reticulum. J Cell Biol. 1999; 145(5):951-9. PMC: 2133123. DOI: 10.1083/jcb.145.5.951. View

15.

Newlon M, Roy M, Morikis D, Carr D, Westphal R, Scott J . A novel mechanism of PKA anchoring revealed by solution structures of anchoring complexes. EMBO J. 2001; 20(7):1651-62. PMC: 145475. DOI: 10.1093/emboj/20.7.1651. View

16.

Mosenden R, Tasken K . Cyclic AMP-mediated immune regulation--overview of mechanisms of action in T cells. Cell Signal. 2010; 23(6):1009-16. DOI: 10.1016/j.cellsig.2010.11.018. View

17.

Smith M, Woodroffe A, Smith R, Holguin S, Martinez J, Filipek P . Molecular genetic delineation of a deletion of chromosome 13q12-->q13 in a patient with autism and auditory processing deficits. Cytogenet Genome Res. 2003; 98(4):233-9. DOI: 10.1159/000071040. View

18.

King L, Kozono D, Agre P . From structure to disease: the evolving tale of aquaporin biology. Nat Rev Mol Cell Biol. 2004; 5(9):687-98. DOI: 10.1038/nrm1469. View

19.

Miyazaki T, Fujiki H, Yamamura Y, Nakamura S, Mori T . Tolvaptan, an orally active vasopressin V(2)-receptor antagonist - pharmacology and clinical trials. Cardiovasc Drug Rev. 2007; 25(1):1-13. DOI: 10.1111/j.1527-3466.2007.00001.x. View

20.

Miki H, Takenawa T . Regulation of actin dynamics by WASP family proteins. J Biochem. 2003; 134(3):309-13. DOI: 10.1093/jb/mvg146. View